Selected research
Industry Research
Biodegradable Injectable Dermal Fillers Industry Research Report 2026
Market perspective
The global Biodegradable Injectable Dermal Fillers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biodegradable Injectable Dermal Fillers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biodegradable Injectable Dermal Fillers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biodegradable Injectable Dermal Fillers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biodegradable Injectable Dermal Fillers include Allergan, BioPlus, Galderma, Glytone, HUGEL, LG Life Sciences, Merz, Sinclair and Teoxane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biodegradable Injectable Dermal Fillers market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biodegradable Injectable Dermal Fillers Market by Company
Allergan
BioPlus
Galderma
Glytone
HUGEL
LG Life Sciences
Merz
Sinclair
Teoxane
Biodegradable Injectable Dermal Fillers Segment by Type
Biodegradable
Non-Biodegradable
Biodegradable Injectable Dermal Fillers Segment by Application
Specialty & Dermatology Clinics
Hospitals & Clinics
Others
Biodegradable Injectable Dermal Fillers Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Injectable Dermal Fillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Injectable Dermal Fillers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Injectable Dermal Fillers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biodegradable Injectable Dermal Fillers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biodegradable Injectable Dermal Fillers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biodegradable Injectable Dermal Fillers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biodegradable
- Non-Biodegradable
Applications
- Specialty & Dermatology Clinics
- Hospitals & Clinics
- Others
Companies covered
- Allergan
- BioPlus
- Galderma
- Glytone
- HUGEL
- LG Life Sciences
- Merz
- Sinclair
- Teoxane
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Biodegradable Injectable Dermal Fillers Market Size (2021-2032)
- 2.2.2 Global Biodegradable Injectable Dermal Fillers Sales (2021-2032)
- 2.2.3 Global Biodegradable Injectable Dermal Fillers Market Average Price (2021-2032)
- 2.3 Biodegradable Injectable Dermal Fillers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Biodegradable
- 2.3.3 Non-Biodegradable
- 2.4 Biodegradable Injectable Dermal Fillers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Specialty & Dermatology Clinics
- 2.4.3 Hospitals & Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biodegradable Injectable Dermal Fillers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Biodegradable Injectable Dermal Fillers Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Biodegradable Injectable Dermal Fillers Revenue of Manufacturers (2021-2026)
- 3.4 Global Biodegradable Injectable Dermal Fillers Average Price by Manufacturers (2021-2026)
- 3.5 Global Biodegradable Injectable Dermal Fillers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Biodegradable Injectable Dermal Fillers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Biodegradable Injectable Dermal Fillers, Product Type & Application
- 3.8 Global Manufacturers of Biodegradable Injectable Dermal Fillers, Established Date
- 3.9 Global Biodegradable Injectable Dermal Fillers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Allergan
- 4.1.1 Allergan Company Information
- 4.1.2 Allergan Business Overview
- 4.1.3 Allergan Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Allergan Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.1.5 Allergan Recent Developments
- 4.2 BioPlus
- 4.2.1 BioPlus Company Information
- 4.2.2 BioPlus Business Overview
- 4.2.3 BioPlus Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BioPlus Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.2.5 BioPlus Recent Developments
- 4.3 Galderma
- 4.3.1 Galderma Company Information
- 4.3.2 Galderma Business Overview
- 4.3.3 Galderma Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Galderma Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.3.5 Galderma Recent Developments
- 4.4 Glytone
- 4.4.1 Glytone Company Information
- 4.4.2 Glytone Business Overview
- 4.4.3 Glytone Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glytone Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.4.5 Glytone Recent Developments
- 4.5 HUGEL
- 4.5.1 HUGEL Company Information
- 4.5.2 HUGEL Business Overview
- 4.5.3 HUGEL Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HUGEL Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.5.5 HUGEL Recent Developments
- 4.6 LG Life Sciences
- 4.6.1 LG Life Sciences Company Information
- 4.6.2 LG Life Sciences Business Overview
- 4.6.3 LG Life Sciences Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LG Life Sciences Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.6.5 LG Life Sciences Recent Developments
- 4.7 Merz
- 4.7.1 Merz Company Information
- 4.7.2 Merz Business Overview
- 4.7.3 Merz Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merz Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.7.5 Merz Recent Developments
- 4.8 Sinclair
- 4.8.1 Sinclair Company Information
- 4.8.2 Sinclair Business Overview
- 4.8.3 Sinclair Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sinclair Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.8.5 Sinclair Recent Developments
- 4.9 Teoxane
- 4.9.1 Teoxane Company Information
- 4.9.2 Teoxane Business Overview
- 4.9.3 Teoxane Biodegradable Injectable Dermal Fillers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teoxane Biodegradable Injectable Dermal Fillers Product Portfolio
- 4.9.5 Teoxane Recent Developments
5 Global Biodegradable Injectable Dermal Fillers Market Scenario by Region
- 5.1 Global Biodegradable Injectable Dermal Fillers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biodegradable Injectable Dermal Fillers Sales by Region: 2021-2032
- 5.2.1 Global Biodegradable Injectable Dermal Fillers Sales by Region: 2021-2026
- 5.2.2 Global Biodegradable Injectable Dermal Fillers Sales by Region: 2027-2032
- 5.3 Global Biodegradable Injectable Dermal Fillers Revenue by Region: 2021-2032
- 5.3.1 Global Biodegradable Injectable Dermal Fillers Revenue by Region: 2021-2026
- 5.3.2 Global Biodegradable Injectable Dermal Fillers Revenue by Region: 2027-2032
- 5.4 North America Biodegradable Injectable Dermal Fillers Market Facts & Figures by Country
- 5.4.1 North America Biodegradable Injectable Dermal Fillers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Biodegradable Injectable Dermal Fillers Sales by Country (2021-2032)
- 5.4.3 North America Biodegradable Injectable Dermal Fillers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Biodegradable Injectable Dermal Fillers Market Facts & Figures by Country
- 5.5.1 Europe Biodegradable Injectable Dermal Fillers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Biodegradable Injectable Dermal Fillers Sales by Country (2021-2032)
- 5.5.3 Europe Biodegradable Injectable Dermal Fillers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Biodegradable Injectable Dermal Fillers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Biodegradable Injectable Dermal Fillers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Biodegradable Injectable Dermal Fillers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Biodegradable Injectable Dermal Fillers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Biodegradable Injectable Dermal Fillers Market Facts & Figures by Country
- 5.7.1 South America Biodegradable Injectable Dermal Fillers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Biodegradable Injectable Dermal Fillers Sales by Country (2021-2032)
- 5.7.3 South America Biodegradable Injectable Dermal Fillers Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Biodegradable Injectable Dermal Fillers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Biodegradable Injectable Dermal Fillers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Biodegradable Injectable Dermal Fillers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Biodegradable Injectable Dermal Fillers Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Biodegradable Injectable Dermal Fillers Sales by Type (2021-2032)
- 6.1.1 Global Biodegradable Injectable Dermal Fillers Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Biodegradable Injectable Dermal Fillers Sales Market Share by Type (2021-2032)
- 6.2 Global Biodegradable Injectable Dermal Fillers Revenue by Type (2021-2032)
- 6.2.1 Global Biodegradable Injectable Dermal Fillers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Biodegradable Injectable Dermal Fillers Revenue Market Share by Type (2021-2032)
- 6.3 Global Biodegradable Injectable Dermal Fillers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Biodegradable Injectable Dermal Fillers Sales by Application (2021-2032)
- 7.1.1 Global Biodegradable Injectable Dermal Fillers Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Biodegradable Injectable Dermal Fillers Sales Market Share by Application (2021-2032)
- 7.2 Global Biodegradable Injectable Dermal Fillers Revenue by Application (2021-2032)
- 7.2.1 Global Biodegradable Injectable Dermal Fillers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Biodegradable Injectable Dermal Fillers Revenue Market Share by Application (2021-2032)
- 7.3 Global Biodegradable Injectable Dermal Fillers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Biodegradable Injectable Dermal Fillers Value Chain Analysis
- 8.1.1 Biodegradable Injectable Dermal Fillers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Biodegradable Injectable Dermal Fillers Production Mode & Process
- 8.2 Biodegradable Injectable Dermal Fillers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Biodegradable Injectable Dermal Fillers Distributors
- 8.2.3 Biodegradable Injectable Dermal Fillers Customers
9 Global Biodegradable Injectable Dermal Fillers Analyzing Market Dynamics
- 9.1 Biodegradable Injectable Dermal Fillers Industry Trends
- 9.2 Biodegradable Injectable Dermal Fillers Industry Drivers
- 9.3 Biodegradable Injectable Dermal Fillers Industry Opportunities and Challenges
- 9.4 Biodegradable Injectable Dermal Fillers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst